百花医药 (600721)

Xinjiang Baihuacun Pharam Tech Co., Ltd.

ASH

Tags

Contract Research Organization (CXO)Long-Term Non-Dividend PayersImmunotherapyWeight Loss DrugsInnovative DrugsMedical ServicesPharmaceuticals and HealthcareSynthetic BiologySmall Cap Non-FinancialMicro and Small Cap StocksMicro Cap Selected StocksProperty ManagementResearch and Experimental DevelopmentHepatitis ConceptDispersed ShareholdingEquity Transfer

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 38454.76
  • Circulating A-Shares(W): 38454.76
  • Earnings Per Share(RMB): 0.0850
  • Net Assets Per Share(RMB): 2.0643
  • Operating Revenue(W RMB): 29860.62
  • Total Profit(W RMB): 3872.00
  • **Net Profit Attributable to Parent(W RMB) **: 3267.42
  • Net Profit Growth Rate(%): 36.41
  • Weighted Return on Equity(%): 4.2100
  • Operating Cash Flow Per Share(RMB): 0.0320
  • Undistributed Profit Per Share(RMB): -4.8650
  • Capital Reserve Per Share(RMB): 5.8975

2. Main Business

The main business covers:

  • Drug discovery
  • Research and technical services
  • Providing full-process services and integrated solutions for new drug development, including drug discovery, CMC, clinical CRO, drug registration, CMO/API supply, etc.

3. Company Basic Information

  • Company Name: Xinjiang Baihuacun Pharmaceutical Group Co., Ltd.
  • Listing Date: 1996-06-26
  • Industry: Research and Experimental Development
  • Address: No. 1 Zhongshan Road South Lane, Tianshan District, Urumqi City, Xinjiang Uygur Autonomous Region
  • Website: https://www.xjbhc.net/
  • Company Profile: The company was established in 1995 through the overall restructuring of the Corps Baihuacun Hotel, a wholly-owned subsidiary of Bingmao Development Center. It initially issued public shares for the first time on June 3, 1996, with its net assets and other sponsors. The total number of shares at the time of listing was 61.275 million.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Xinjiang Xinnong Modern Investment Development Co., Ltd. General Legal Person 1687.36 4.39
2 Ningbo Meishan Bonded Port Area Daokang Xiangyun Investment Partnership (Limited Partnership) General Legal Person 492.85 1.28
3 Shanghai Jiaqi Asset Management Center (Limited Partnership) General Legal Person 382.50 0.99
4 China Securities Investor Protection Fund Co., Ltd. General Legal Person 342.81 0.89
5 Xinjiang Bingshe Property Management Co., Ltd. General Legal Person 307.21 0.80
6 Huatai-PineBridge CSI 2000 Index Enhanced Securities Investment Fund Class A Fund 108.91 0.28

5. Concept Sectors

  • Immunotherapy
  • CXO Concept
  • Property Management
  • Hepatitis Concept
  • Innovative Drugs
  • Weight Loss Drugs
  • Synthetic Biology

Remarks

  • Data update date: 2025-11-01
  • Data source: Public market information